Eyecare biotech jumps 19% after stablecoin-focused pivot
NovaBay Pharmaceuticals was founded in 2000 as a biopharmaceutical company developing eye care products and is now betting big on the Sky protocol and stablecoins.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
NovaBay Pharmaceuticals was founded in 2000 as a biopharmaceutical company developing eye care products and is now betting big on the Sky protocol and stablecoins.
Why this matters
This maps to the Stablecoins hub, so it can help confirm whether that theme is gaining breadth across the crypto news cycle.
Original source
Read on CointelegraphRelated market context
Ledger hack scare nears $90 million as Tether moves to freeze stolen USDT
Suspected Ledger wallet thefts are approaching $90 million as Tether freezes USDT stablecoin linked to the incident, according to...
NEAR Protocol jumps 16% as trading activity surges over weekend
NEAR's surge highlights growing investor interest in cross-chain solutions and ETFs, potentially influencing broader altcoin marke...
Bitcoin miners need roughly $50 billion to finish their AI pivot
Bitcoin miners' AI pivot demands massive funding, potentially reshaping investment strategies and partnerships beyond traditional...
Bitunix analysts flag $82,800 as pivotal Bitcoin level as ETF demand weakens
Bitcoin's struggle to reclaim $82,800 amid ETF outflows highlights market volatility and the need for stronger demand to stabilize...
Base creator predicts tokenization supercycle led by equities, non-dollar stablecoins
The predicted tokenization supercycle could reshape financial markets, influencing Base's strategic direction and broader crypto a...
FTX’s former Bitcoin mining bet gets new life as parent raises €800 million for AI
SWI Group has raised €800 million to expand AI infrastructure, advancing its plan to repurpose FTX-backed Bitcoin miner Genesis Di...